Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:DCCPFNASDAQ:LFSTNASDAQ:PRVANASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCCPFDCC$61.88$64.32$61.88▼$73.38$6.12B0.81266 shsN/ALFSTLifeStance Health Group$5.15+1.4%$5.79$4.76▼$8.61$2.00B1.221.65 million shs5.23 million shsPRVAPrivia Health Group$22.00$23.16$16.47▼$26.09$2.68B0.83753,931 shs2.71 million shsWGSGeneDx$91.10+1.7%$74.52$25.32▼$117.75$2.60B1.94815,599 shs1.88 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCCPFDCC0.00%0.00%-0.40%-7.98%-15.81%LFSTLifeStance Health Group0.00%+6.63%-12.86%-23.13%+7.07%PRVAPrivia Health Group0.00%+0.69%-2.44%-2.61%+33.50%WGSGeneDx0.00%+35.97%+30.18%-1.19%+247.84%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDCCPFDCCN/AN/AN/AN/AN/AN/AN/AN/ALFSTLifeStance Health Group2.4149 of 5 stars3.41.00.00.02.82.50.6PRVAPrivia Health Group4.1176 of 5 stars4.52.00.00.02.23.31.9WGSGeneDx1.8709 of 5 stars1.42.00.00.01.94.21.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCCPFDCC 3.67Strong BuyN/AN/ALFSTLifeStance Health Group 2.83Moderate Buy$8.5065.05% UpsidePRVAPrivia Health Group 3.00Buy$27.7726.22% UpsideWGSGeneDx 2.75Moderate Buy$86.75-4.77% DownsideCurrent Analyst Ratings BreakdownLatest DCCPF, PRVA, LFST, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$8.505/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/19/2025DCCPFDCCRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.005/1/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.004/28/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$29.00 ➝ $29.004/15/2025PRVAPrivia Health GroupRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$24.00 ➝ $26.004/10/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.00(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCCPFDCC$22.98B0.27$9.92 per share6.24$40.85 per share1.51LFSTLifeStance Health Group$1.25B1.60$0.04 per share129.88$3.78 per share1.36PRVAPrivia Health Group$1.74B1.54$0.18 per share121.92$5.70 per share3.86WGSGeneDx$305.45M8.51$1.02 per share89.03$8.75 per share10.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCCPFDCC$263.46MN/A0.00∞N/AN/AN/AN/AN/ALFSTLifeStance Health Group-$57.44M-$0.10N/AN/AN/A-2.78%-2.47%-1.69%8/14/2025 (Estimated)PRVAPrivia Health Group$14.39M$0.12183.3581.483.520.87%2.32%1.38%8/14/2025 (Estimated)WGSGeneDx-$52.29M-$1.41N/A43.59N/A-11.69%10.17%5.51%7/29/2025 (Estimated)Latest DCCPF, PRVA, LFST, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCCPFDCCN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCCPFDCC0.661.300.99LFSTLifeStance Health Group0.191.471.47PRVAPrivia Health GroupN/A1.881.88WGSGeneDx0.203.253.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCCPFDCCN/ALFSTLifeStance Health Group85.50%PRVAPrivia Health Group94.48%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipDCCPFDCCN/ALFSTLifeStance Health Group3.20%PRVAPrivia Health Group10.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCCPFDCC16,60098.97 millionN/ANot OptionableLFSTLifeStance Health Group10,218388.88 million376.43 millionOptionablePRVAPrivia Health Group1,140121.92 million108.88 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableDCCPF, PRVA, LFST, and WGS HeadlinesRecent News About These CompaniesLisanti Capital Growth LLC Cuts Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)June 29 at 6:33 AM | marketbeat.comGeneDx (WGS) Stock Gains After AAP Endorses Russell 1000June 28 at 6:03 AM | kalkinemedia.comKWhy GeneDX Stock Surged Higher This WeekJune 27 at 8:00 PM | finance.yahoo.comGeneDx Holdings Corp.'s (NASDAQ:WGS) Profit OutlookJune 26 at 10:53 PM | uk.finance.yahoo.comChung Wu Investment Group LLC Makes New $270,000 Investment in GeneDx Holdings Corp. (NASDAQ:WGS)June 26 at 7:29 AM | marketbeat.comBrokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $86.75June 26 at 2:23 AM | americanbankingnews.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 25, 2025 | globenewswire.comInsiders Invested Millions in these Five Rebounding StocksJune 25, 2025 | 247wallst.comGeneDx Holdings Breaks Above 200-Day Moving Average - Bullish for WGS - NasdaqJune 25, 2025 | nasdaq.comGeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of PediatricsJune 25, 2025 | businesswire.comWGS GeneDx Holdings Corp. - Seeking AlphaJune 25, 2025 | seekingalpha.comWhy GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two DaysJune 25, 2025 | msn.comGeneDx (NASDAQ:WGS) Shares Up 7.5% - What's Next?June 24, 2025 | marketbeat.comGeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last?June 24, 2025 | zacks.comGeneDx stock soars after AAP recommends genome testing as first-tier testJune 23, 2025 | investing.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJune 23, 2025 | prnewswire.comGeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual DisabilityJune 23, 2025 | businesswire.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Recommendation of "Moderate Buy" from BrokeragesJune 23, 2025 | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...June 22, 2025 | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 22, 2025 | globenewswire.comGeneDx (NASDAQ:WGS) Downgraded by Wall Street Zen to "Hold"June 22, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDCCPF, PRVA, LFST, and WGS Company DescriptionsDCC OTCMKTS:DCCPF$61.88 0.00 (0.00%) As of 06/27/2025DCC plc provides sales, marketing, and support services worldwide. The company operates through DCC Energy, DCC Healthcare, and DCC Technology segments. It sells and markets liquefied petroleum gas (LPG), refrigerants, and natural gas; markets, sells, and retails transport and commercial fuels, heating oils, and related products and services; operates retail petrol stations; resells fuel cards; distributes oil; and provides logistics services. It also offers products and services to healthcare providers, and health and beauty brand owners; contract manufacturing services to the health and beauty sector; nutrition products, such as vitamins and health supplements; beauty products; and product development, formulation, manufacturing, and packaging services. In, addition it distributes consumer technology products, including smart home products, peripherals and software, and accessories, as well as provides supply chain services. The company was founded in 1976 and is headquartered in Dublin, Ireland.LifeStance Health Group NASDAQ:LFST$5.15 +0.07 (+1.38%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$5.12 -0.03 (-0.60%) As of 06/27/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Privia Health Group NASDAQ:PRVA$22.00 0.00 (0.00%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$22.00 0.00 (-0.02%) As of 06/27/2025 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.GeneDx NASDAQ:WGS$91.10 +1.51 (+1.69%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$90.78 -0.32 (-0.36%) As of 06/27/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
